Newsletter | August 29, 2026
PATIENT CENTRICITY
This Isn't Just A Compliance Exercise
Clinical Leader Live
What To Know About The European Biotech Act
Scout
CLINICAL SITES
Don't Accept This Site-Level Start-Up Bottleneck— Instead, Learn How To Stop It
By Celin Sabu
Participant Payments: Navigating Modern Studies
By Shaun Williams, IQVIA Technologies
PATIENT RECRUITMENT
Why Representation Is More Than A Diversity Checkbox
How Community-Based Research Models Expand Access
By Miranda McLaren, EmVenio Clinical Research
CLINICAL TRIAL TECHNOLOGY
Understanding And Preserving Data Flow Integrity In AI-Assisted Clinical Trials
By Dawn Wydner, Ph.D., ELIQUENT Life Sciences
Unifying Research - Research Compliance And Patient Stephanie
Univo IRB
Reduction Of Screen Failures In A Biomarker
Flourish Research
Why Protocol‑Driven eSource Solves Data Capture For 80% Of Sites
By Jonathan Andrus, CRIO
DECENTRALIZED TRIALS
Ask An Expert Before Shredding Your Mobile Device CAPEX
By Brad Grimes
Finding The Solution(s) That Meet Patient, Site, And Sponsor Needs
MRN - Medical Research Network
TRIAL MANAGEMENT
The U.S. Clinical Trial Recruiting Pipeline Report – June 2026
By Andrew Beauchamp, WhichTrial.com
Big Futures For Emerging Biopharma: Navigating Biotech Hurdles
By Matthew Simmons, IQVIA Biotech
The Protocol Amendment Trap (And How Sponsors Free)
Precision for Medicine
Capital Efficiency In Cardiovascular Outcomes Trials
PPD Clinical Research Business of Thermo Fisher Scientific
Advances In Metabolic Research: Beyond GLP-1
Altasciences
Streamline Pediatric Clinical Trials And Reduce Documentation Errors
McCreadie Group
The Challenge: Complexity In Modern Clinical Trials
Suvoda
OUTSOURCING MODELS
What Sponsors Value Most In CRO Partnerships
By Roula Krayem, Zachary Smith, and Ken Getz, Worldwide Clinical Trials Oncology
How Many Vendors Does One Trial Really Need?
Block Clinical Inc.
REGULATORY COMPLIANCE
What The FDA's Psychedelic Drug Focus Means For Classic Psychedelic Development
A conversation between Josh Hardman and Clinical Leader Executive Editor Abby Proch
Who Decides? Navigating AI Governance in Clinical Research
By Andrea Bastek, Florence Healthcare
What UK Regulatory Changes Mean For Drug Developers And Sponsors
By Shawn Murtough, PCI Pharma Services
10 Clinical Research Practices That Feel Like Compliance (But Aren't)
BRANY
TRIAL MONITORING
How Regulatory Convergence Is Rewriting Clinical Data Management
By Life Science Connect Editorial Staff
Next-Generation ADC Trials – Turning Complexity Into Execution
By Jozsef Palatka, M.D., Parexel International
Startup To Signal Detection: Building An Integrated Safety Framework
By PrimeVigilance, Ergomed Group
Real-Time RTSM Integration Monitoring For Sponsors
Korio
CLINICAL DATA MANAGEMENT & ANALYTICS
Building The Execution Architecture For Real-World Data To Have Real-World Impact
By Steven C. Grambow, Drew Narayan, Steve Frank, Norm Goldberg, Gwyn Cready, and Hayden B. Bosworth
Collaborate With AI To Improve Quality, Speed, And Agility In Study Build
Endpoint Clinical
Why AI Matters In Early Phase Clinical Trials
CHDR
